Author Correction: A PP1–PP2A Phosphatase Relay Controls Mitotic Progression

Why It Matters

Accurate visual data are essential for reproducibility in cell‑division research, and this correction safeguards the credibility of a high‑impact study on mitotic regulation.

Key Takeaways

• Duplicate anti‑HA blot identified in Extended Data Fig. 7c
• Corrected blot replaces duplicated image with original experiment data
• Supplementary file now hosts revised Figure 7c and e
• Correction maintains study’s conclusions on PP1‑PP2A relay
• Reader vigilance prompted amendment, highlighting community oversight

Pulse Analysis

Post‑publication scrutiny remains a cornerstone of scientific rigor, especially in high‑profile journals where data are rapidly disseminated. When a vigilant reader flagged a duplicated anti‑HA blot, the authors responded by issuing a formal correction and supplying the accurate image as supplementary material. This episode illustrates how community oversight can quickly rectify inadvertent errors, preserving the trustworthiness of the scientific record and reinforcing the collaborative nature of modern research.

The PP1‑PP2A phosphatase relay is a pivotal regulator of mitotic progression, coordinating dephosphorylation events that ensure proper chromosome segregation. Precise biochemical evidence, such as immunoblot controls, underpins mechanistic models that guide drug discovery and synthetic biology applications. By correcting the blot, the authors reaffirm that the experimental foundation for their conclusions remains solid, allowing downstream labs to build on validated findings without questioning the assay’s reliability.

Beyond the immediate study, this correction highlights broader trends in scholarly publishing: increasing transparency, the rise of supplemental data repositories, and the expectation that authors promptly address even minor visual discrepancies. As journals adopt more rigorous image‑screening tools, the scientific community benefits from heightened confidence in published figures. Researchers can therefore focus on expanding the PP1‑PP2A narrative—exploring therapeutic targets in cancer and developmental disorders—knowing that the underlying data have been vetted and corrected where necessary.